Concepedia

Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

Suzanne Craft

Archives of Neurology · 2011 · 1.2K citations · 26 references

DOI

Abstract

These results support longer trials of intranasal insulin therapy for patients with amnestic mild cognitive impairment and patients with AD. Trial Registration clinicaltrials.gov Identifier: NCT00438568.

References

26

A new rating scale for Alzheimer's disease

Wilma G. Rosen, Richard C. Mohs, Kenneth L. Davis · American Journal of Psychiatry · 1984 · 4.1K citations

, , +14

A Three-Dimensional Statistical Analysis for CBF Activation Studies in Human Brain

Keith J. Worsley, Alan C. Evans, Sean Marrett et al. · Journal of Cerebral Blood Flow & Metabolism · 1992 · 2.1K citations · Full text

, , +22

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

Eric van Steen, Benjamin M. Terry, Enrique J. Rivera et al. · Journal of Alzheimer s Disease · 2005 · 1.7K citations

Sniffing neuropeptides: a transnasal approach to the human brain

Jan Born, Tanja Lange, Werner Kern et al. · Nature Neuroscience · 2002 · 1.3K citations

, , +8

An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimerʼs Disease

Douglas Galasko, David A. Bennett, Mary Sano et al. · Alzheimer Disease & Associated Disorders · 1997 · 1.2K citations

, , +17